Kidswell Bio Corporation
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Kidswell Bio Corporation made a loss over the last year. Kidswell Bio Corporation owes ¥0.70 for every ¥1 it owns. Kidswell Bio Corporation made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossKidswell Bio Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.03The share price is 4.03 times Kidswell Bio Corporation's book value per share, higher than 83% of Healthcare companies in Japan.
Market cap
¥7.4 BThe total market value of all of Kidswell Bio Corporation's shares at today's price (share price × number of shares), smaller than 68% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥1.8 BWhat Kidswell Bio Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥37.02Net worth divided by the number of shares. The share price of ¥149.00 is 4.0 times this, which is the P/B above.
Return on equity (ROE)
-19.2%Kidswell Bio Corporation lost 19.2% of its shareholders' money over the last year, lower than 81% of Healthcare companies in Japan.
Owes vs Owns
0.70×Kidswell Bio Corporation owes ¥0.70 for every ¥1 it owns (moderate), higher than 86% of Healthcare companies in Japan.
Dividend yield
NoneKidswell Bio Corporation does not currently pay a dividend.
Revenue growth
+30%Revenue rose 30% in the year to Mar 2026, and grew 33% a year on average over 3 years.
Profit growth
LossKidswell Bio Corporation made a loss in each of the last two years.
Profit margin
-6.3%Kidswell Bio Corporation lost ¥6 for every ¥100 of revenue.
Interest cover
Not coveredKidswell Bio Corporation's operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net cashKidswell Bio Corporation held ¥745 M more cash than debt (net cash) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Kidswell Bio Corporation: ¥7.4 B ÷ ¥1.8 B (30 Jun 2026) = 4.0.
What is Kidswell Bio Corporation's return on equity?
Kidswell Bio Corporation lost 19.2% of its shareholders' money over the last year, lower than 81% of Healthcare companies in Japan.
How much does Kidswell Bio Corporation owe compared with what it owns?
Kidswell Bio Corporation owes ¥0.70 for every ¥1 it owns (moderate), higher than 86% of Healthcare companies in Japan.
Does Kidswell Bio Corporation pay a dividend?
No. Kidswell Bio Corporation does not currently pay a dividend.
Is Kidswell Bio Corporation's revenue growing?
Revenue rose 30% in the year to Mar 2026, and grew 33% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.